Candidate targets for hepatitis C virus-specific antiviral therapy

Area of Science:

• Virology
• Molecular Biology
• Drug Discovery

Background:

• Hepatitis C virus (HCV) is a global health concern, causing non-A, non-B hepatitis.
• HCV is an enveloped virus with a plus-strand RNA genome encoding a polyprotein.
• Viral polyprotein processing involves host and viral proteases, including NS2-3 and NS3/4A.

Purpose of the Study:

• To review current knowledge on the structure and function of key HCV proteins.
• To identify promising targets for HCV-specific antiviral therapies.
• To summarize approaches for developing effective antiviral compounds against HCV.

Main Methods:

• Review of existing scientific literature on HCV protein structure and function.
• Analysis of viral enzymes critical for HCV replication.
• Examination of drug development strategies targeting viral proteases and polymerases.

Main Results:

• The NS3/4A serine-type proteinase complex, NS3 NTPase/helicase, and NS5B RNA-dependent RNA polymerase (RdRp) are essential for HCV replication.
• These proteins are attractive targets for antiviral drug development due to their crucial roles.
• Information on related cellular and viral proteins provides insights for targeting HCV enzymes.

Conclusions:

• Targeting NS3/4A protease, NS3 helicase, and NS5B RdRp holds significant promise for developing novel HCV antiviral therapies.
• Further research into the structure-function relationships of these proteins is crucial for advancing treatment options.
• The development of effective antiviral compounds against HCV relies on a deep understanding of these viral targets.